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Abstract
Background: The past decade has seen considerable interest in the development and evaluation of complex
interventions to improve health. Such interventions can only have a significant impact on health and health care if
they are shown to be effective when tested, are capable of being widely implemented and can be normalised into
routine practice. To date, there is still a problematic gap between research and implementation. The Normalisation
Process Theory (NPT) addresses the factors needed for successful implementation and integration of interventions
into routine work (normalisation).
Discussion: In this paper, we suggest that the NPT can act as a sensitising tool, enabling researchers to think
through issues of implementation while designing a complex intervention and its evaluation. The need to ensure
trial procedures that are feasible and compatible with clinical practice is not limited to trials of complex
interventions, and NPT may improve trial design by highlighting potential problems with recruitment or data
collection, as well as ensuring the intervention has good implementation potential.
Summary: The NPT is a new theory which offers trialists a consistent framework that can be used to describe,
assess and enhance implementation potential. We encourage trialists to consider using it in their next trial.
Background
Complex interventions
Understanding, developing and evaluating complex
interventions is essential for improving health and
healthcare. Ten years ago, the Medical Research Council
(MRC) published its highly influential framework for
developing and evaluating interventions that ‘are built
up from a number of components, which may act both
independently and inter-dependently’ [[1], page 2]. The
MRC framework has been extended and refined [2,3],
emphasising, for example, that the early phases of a trial
should be seen as iterative rather than linear [2,3]; that
both intervention development and evaluation require a
strong theoretical foundation [4]; that detailed
descriptions of the intervention and the context of the
evaluation are needed [2,5]; that modelling to estimate
the potential benefits is important before proceeding to
a trial [6,7]; and that qualitative methods can assist with
understanding the processes involved in the intervention
and evaluation [8,9].
The revised framework has proved invaluable for
health service researchers, but there remain substantial
problems in the design and conduct of complex inter-
ventions. For example, recruitment to trials remains
problematic; a review of trials funded by the UK’s
Health Technology Assessment or the Medical Research
Council found that less than one third of funded trials
recruited up to their original target [10].
While the factors contributing to successful recruit-
ment were difficult to ascertain, the authors suggested
that trials which were clearly grounded in existing clini-
cal practice had a greater chance of successful recruit-
ment, probably because recruitment for the trial did not
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require additional effort from its clinical collaborators.
The results from such trials were also deemed to be
more readily applicable to future practice.
Another substantive problem is the gap between
research evidence and practice, which remains wide,
with at least two recognised gaps [11-13]. The first
translational gap refers to the difficulties and barriers of
moving from laboratory-based basic research to clinical
medicine. The second gap focuses on the gap between
developing new treatments and knowledge and imple-
menting these in practice for the patient or population
groups for which they are intended. While recognition
of these gaps in the research process is valuable, a third
translational gap is also evident: that of using the results
of such health services research to inform wider health-
related policy and practice. Such implementation failures
are often attributed to slow behaviour change by profes-
sionals, but there may be other good and predictable
socio-organisational reasons for such failure, including
time constraints during consultations and patient prefer-
ence [14]. Wider societal and contextual barriers are
also present, in particular engaging policymakers in the
research process, where research often does not proceed
within a timeline suited to that of the policy agenda.
Policy makers also engage with and use research evi-
dence in complex ways, with the context and timing in
which research findings become available as important
as the evidence itself [15-17].
To overcome some of these difficulties, a number of
strategies have been proposed which should be heeded
by researchers interested in having their findings imple-
mented into practice and policy. These include a greater
role for theoretical approaches in research focused on
implementation; consideration of how new research
findings are sustained in practice; and use of a wide
range of methods appropriate to the policy questions
and the wider social context in which they are placed
[15,18]. If these wider issues are not considered during
the design of a trial, there is a risk that there will be
interventions which are never implemented, despite
being shown to be effective. Interventions which are not
implemented will not improve health or health care.
This requires both researchers designing complex inter-
ventions and research funders to consider whether an
intervention exhibits the required potential for future
implementation into routine practice, if demonstrated to
be effective. We argue that the implementation and sus-
tainability of interventions can be considered from the
very beginning of their development and evaluation by
using Normalisation Process Theory (NPT).
Normalisation Process Theory
NPT [19,20] identifies factors that promote and inhibit
the routine incorporation of complex interventions into
everyday practice. It also explains how these interven-
tions work, looking not only at early implementation,
but beyond this to the point where an intervention
becomes so embedded into routine practice that it ‘dis-
appears’ from view (i.e., it is normalised). Normalisation
is not irrevocable: practices can be denormalised; for
example, few people now use a typewriter. Neither is
normalisation necessarily desirable: plenty of ineffective
or inefficient practices are widely normalised (overpre-
scription of antibiotics being one example) [21].
The NPT focuses on the work that individuals and
groups do to enable an intervention to become normal-
ised. There are four main components to NPT: coher-
ence (or sense-making); cognitive participation (or
engagement); collective action (work done to enable the
intervention to happen); and reflexive monitoring (for-
mal and informal appraisal of the benefits and costs of
the intervention). These components are not linear, but
are in dynamic relationships with each other and with
the wider context of the intervention, such as organisa-
tional context, structures, social norms, group processes
and conventions.
In this paper, we discuss the role of NPT in develop-
ing, evaluating and implementing complex interventions
and provide worked examples (derived from our experi-
ence) of applying NPT to these tasks.
Discussion
It is important to distinguish clearly between the inter-
vention (which would continue if it were subsequently
implemented) and the evaluation of the intervention
(which would not continue). Both can be analysed using
NPT, as we demonstrate below.
Use of NPT to develop a complex intervention
Define the context
However efficacious an intervention is shown to be in
an experimental environment, its long-term impact
depends both on its effectiveness in the “real world” and
on how widely it is implemented. Researchers need to
consider implementation issues during the initial inter-
vention development, including considering the context
where it will be deployed and how any changes may
affect the effectiveness of the planned intervention.
Change often renders a well-designed intervention irre-
levant: a trial of an intervention to reduce cigarette
smoking in public places may be redundant if legislation
is introduced prohibiting smoking in public buildings.
Hence a first task for researchers is to describe the con-
text in which the proposed intervention would be imple-
mented and to consider any likely changes and the likely
implications of these for the proposed intervention.
Questions to address include defining the staff groups
affected by the intervention, considering their main
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current and foreseeable future concerns, and determin-
ing whether the proposed intervention will fit with these
concerns. Although trial reporting standards call for a
description of context [22], there is little guidance on
how to do this. NPT provides a framework for mapping
important elements of trial context by alerting research-
ers to a range of relevant contextual issues.
For example, NPT has proven valuable in understand-
ing the context into which an intervention to promote
evidence-based care of patients with back pain in UK
primary care was set (the ImPACT study; Table 1). The
pressures of time and the complexity of the consultation
shape the context in which GPs work. In relation to
back pain, not all patients presented with back pain as
their primary condition, and it was often mentioned
only in passing by the patient. The lack of prominence
of back pain within the context of the consultation
meant that the ImPACT’s initial intervention to pro-
mote care for back pain had low coherence (focusing on
one condition made little sense to GPs within the wider
context of the consultation) and thus led to low cogni-
tive participation and collective action. NPT clarified
understanding of this problem and led to changes in the
design of the trial, including attaching a GP to the pro-
ject who acted as a peer advisor to GP participants and
reengaged their interest in using the referral template.
Define the intervention
The next task is to define the intervention. This is
demonstrated through the example shown in Table 1.
Physiotherapists were trained to provide psychological
support to patients with low back pain, and GPs were
asked to use paper- or computer-based decision support
tools to assess patients with back pain and refer those at
risk of developing chronic low back pain to these spe-
cially trained physiotherapists [23].
Undertake an NPT analysis of the intervention
As shown in Table 1, the intervention had low coher-
ence for participating GPs, who mainly focused on one
aspect (the decision-support tool), which did not make
clinical sense to them. Because of this low coherence,
there was low cognitive participation, with the GPs see-
ing little point to the intervention, which led in turn to
low collective action (an unwillingness to invest time or
energy in implementation), particularly as the interven-
tion required a change in consultation behaviour. GPs
tended to ignore the decision-support tool and to focus
on the length of waiting lists when making referral deci-
sions. As a result, patients were not referred to the
enhanced physiotherapy treatment and GPs did not
receive positive feedback about the new service (low
reflexive monitoring).
Addressing the questions outlined in Table 1 is likely
to need a mixture of literature reviews and primary
data collection (e.g., observation, interviews, and/or
questionnaires). This analysis allowed the researchers to
redesign future interventions, improving their coherence
and fit with existing consultation practices so that GPs
could easily grasp what was involved, tailor their work
practices and see the potential benefit for patients. For
example, using NPT within ImPACT emphasised the
importance of understanding the varied contexts of pri-
mary care (e.g., number of partners, communication
between GPs, models of team working, use of guide-
lines), how to gain participation (e.g., through the use of
champions) and maintain this (e.g., through peer sup-
port), highlighting the potential benefits of participation
in the trial and the ‘fit’ with routine practice. Such
insights were subsequently used in the design of another
large implementation study.
With ImPACT, the NPT informed the redesign of the
intervention for subsequent studies to enhance its
potential for normalisation. Sometimes this may not be
possible, and in this case researchers may need to con-
sider whether proceeding to a more formal evaluation is
justified. In some cases, the potential benefits may be
sufficient to justify continuing and working on overcom-
ing barriers to normalisation. In other cases, researchers
may be better advised to abandon the intervention,
rather than using scarce research funds to assess an
intervention that has little chance of implementation.
This is an example of NPT acting as a ‘trial killer’ (Fig-
ure 1). While we have discussed this in relation to the
design and evaluation of trials of complex interventions,
the principles can also be applied to clinical trials of
new drug treatments or medical devices. If there is little
likelihood of the treatment or device being normalised
into either routine clinical practice or the patients’ lives,
for example, because of the demands the treatment regi-
men makes of patients [24], then the trial should be
reconsidered or abandoned.
Use of NPT to optimise evaluation of a complex
intervention
NPT can also be used to guide the design of the evalua-
tion of a complex intervention. In this paper, we focus
on optimisation of trial parameters, but a similar
approach can be used for other evaluative methodolo-
gies as well as clinical trials of noncomplex interven-
tions. Table 2 presents a worked example derived from
the Whole System Informing Self-management Engage-
ment (WISE) trial [25]. The trial aimed to evaluate a
whole systems approach to improving outcomes in
long-term conditions through effective self-management.
The intervention involved training a whole practice
team to provide self-care support for patients. As part
of the optimisation of trial parameters (recruitment), the
study team undertook an exploratory study to help opti-
mise the content of the training and ensure that the
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Table 1 Use of NPT in developing complex interventions
NPT Components Questions to consider within the NPT framework Example: NPT evaluation of the ImPACT back pain
study
Coherence Is the intervention easy to describe? Participating GPs did not differentiate the new
intervention from current practice and were unable to
perceive the projected benefits to patients, primary
care teams and physiotherapists.
Is it clearly distinct from other interventions?
(i.e., meaning and sense
making by participants)
Does it have a clear purpose for all relevant participants?
Do participants have a shared sense of its purpose?
What benefits will the intervention bring and to whom?
Are these benefits likely to be valued by potential participants?
Will it fit with the overall goals and activity of the organisation?
Cognitive
participation
Are target user groups likely to think it is a good idea? Participating GPs saw it as research (i.e., recruiting
patients to the study), and peripheral to their main
task of delivering patient care. Projected benefits were
not obvious to the GPs so they were insufficiently
motivated to invest thought and energy into
changing their practice.
(i.e., commitment and
engagement by
participants)
Will they see the point of the intervention easily?
Will they be prepared to invest time, energy and work in it?
Collective action How will the intervention affect the work of user groups? Participating GPs were expected to use a computer-
based decision-support tool during consultations.
Many GPs did not access the computer until after the
consultation was completed. GPs were unconvinced
that such a brief tool could form an appropriate basis
for decisions about referral.
Will it promote or impede their work?
(i.e., the work
participants do to make
the intervention
function)
What effect will it have on consultations?
Will staff require extensive training before they can use it? GPs were not fully aware of the additional training
received by participating physiotherapists, and did not
therefore realise that the physios were well equipped
to deal with emotional or psychological components
of back pain.
How compatible is it with existing work practices? GPs already felt under pressure of time in
consultations, and felt that using the decision-support
tool was an unjustified additional use of time.
What impact will it have on division of labour, resources, power,
and responsibility between different professional groups?
Will it fit with the overall goals and activity of the organisation?
Reflexive Monitoring How are users likely to perceive the intervention once it has been
in use for a while?
Despite regular feedback from the research team GPs
did not perceive benefits to the new system as they
did not use it enough.
(i.e., participants reflect
on or appraise the
intervention)
Is it likely to be perceived as advantageous for patients or staff?
Will it be clear what effects the intervention has had?
Can users/staff contribute feedback about the intervention once it
is in use?
Can the intervention be adapted or improved on the basis of
experience?
The UK ImPACT back study aims to promote evidence-based care of patients with back pain in primary care[23]. Physiotherapists were trained to provide
psychological support to patients with low back pain, and GPs were asked to use paper-based or computer-based decision-support tools to assess patients with
back pain and refer those at risk of developing chronic low back pain to these specialised physiotherapists. As a result of the analysis presented here, the
intervention could be modified to provide greater coherence to the GPs, and hence greater cognitive participation as well as modifications which enabled better
fit with existing GP consultation practices.
The context for this intervention was UK primary care. GPs were a potential rate-limiting factor as they had to use the intervention to refer patients to the
specialised physiotherapists. GPs main concerns were providing high quality care under extreme pressure of time while responding to multiple other changes in
primary care. Many UK GPs reported feeling under pressure and suffering from “change fatigue”, leading to a concentration on “core business” rather than
“optional extras” such as research or teaching.
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Figure 1 Normalisation Process Theory (NPT) as a ‘trial killer’. Context: All important for development, evaluation and implementation.
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Table 2 Use of NPT in optimising trial parameters
NPT Components Questions to consider within the NPT framework Example: an NPT evaluation of the WISE trial
Coherence Is the trial easy to describe? Yes, practices understood the trial explored whether providing
training to the practice team affected patient ability to self-care.
(i.e., meaning and sense
making by participants)
Is it clearly distinct from other studies? Recruitment was in two stages: practice recruitment and
randomisation to either immediate training or training after 1
year, and then patient recruitment in the first year. Outcomes
data collected at the level of the individual patient, so good
communication about the timing of training and patient
recruitment was required.
Does it have a clear purpose for all relevant
participants?
Providing self-care support may require clinicians to challenge
current patient behaviours and risks disrupting existing
relationships. Hence during practice recruitment the emphasis
was on the benefits of the training, including development of
practical strategies and improving skills which would benefit
patient care.
Do participants have a shared sense of its purpose?
What benefits will the trial bring and to whom? Patients were unlikely to perceive any direct personal benefit
from participation, and so financial incentives were required to
improve completion of postal questionnaires. The initial
informed consent process was found to be a potential ‘trial
killer’ as it had a very negative impact on patient recruitment
rates. Ethical approval was sought and obtained to simplify the
process.
Are these benefits likely to be valued by potential
participants?
Will it fit with the overall goals and activity of the
organisation?
Cognitive participation Are target user groups likely to think the trial is a
good idea?
Clinicians may hold the view that their patients do not want to
be self-managers, and provide evidence to challenge this.
Alternatively, they may see potential benefits in reduced
workload with these patient groups.
(i.e., commitment and
engagement by
participants)
Will they see the point of the trial easily?
Will they be prepared to invest time, energy and
work in it?
Patients may have altruistic reasons for participating (e.g.,
improving future provision of self care support for others) which
can be drawn on to encourage continuing participation.
Collective action How will trial procedures affect the work of user
groups?
Participation ensures controlled access to desired resources such
as additional Cognitive Behavioural Therapy and patient
information books which may incentivise participation.
Will they promote or impede their work?
(i.e., the work participants
do to make the
intervention function)
What effect will it have on consultations? General practice staff concerns about increased time burden will
need to be addressed.
Will participation in the trial require extensive
training for staff involved?
For staff, the trial provides an opportunity to have protected
training time together which is unusual and appreciated but
needs additional financial resources.
How compatible is the trial with existing work
practices?
Initial input is needed from practice staff to recruit patients to
the trial and service support costs provided by the research
body are an encouragement for practices. Once patients are
recruited, the research team takes over the burden of patient
follow-up.
What impact will it have on division of labour,
resources, power, and responsibility between
different professional groups?
It is hard to engage GP practices with research, and sustained
support from the PCT and early adopters (practices who
participated first and champion the research) have been key to
engaging other practices in the PCT.
Will the trial fit with the overall goals and activity of
the organisation?
Reflexive Monitoring How are users likely to perceive the trial once it’s
been on-going for a while?
Trainers in self care support can provide ongoing contact,
feedback and help the practice access resources for their
patients, so effects should be visible quickly.
Is it likely to be perceived as advantageous for
patients or staff?
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research protocol was acceptable to the service users,
professionals and organizations targeted.
Define the context
Considering the context of the evaluation is as essential
as considering the context of the intervention. Questions
to consider include identifying systems already in place
and considering how well the proposed trial procedures
fit with these systems. Are any major changes to the
trial context likely to occur during the trial period? For
example, running a trial in a setting that is undergoing
major reorganisation is unlikely to be easy, as staff may
be unable or unwilling to engage with the study. As
described in Table 2, consideration of the timing of
patient recruitment and data collection was crucial. If
these activities overlapped with the end-of-year work-
load of practices collecting routine clinical data for the
Quality and Outcomes Framework [26], the trial could
be incompatible with practice workload (a negative
impact on collective action), with practices less likely to
conduct the work required for the trial.
Define the trial parameters and consider all the different
patient and professional groups likely to be affected
Researchers are used to defining the trial parameters
(recruitment, randomisation, data collection, outcome
measures and follow-up). Many researchers are less
used to thinking about the impact of the trial proce-
dures on the work of all the people affected by the trial,
including health professionals, patients and support staff.
Undertake an NPT analysis of the trial parameters
Having considered all the different professional and
patient groups likely to be involved in the work of the
trial, the researcher needs to consider how the trial pro-
cedures will affect them. Will the trial make sense and
appear relevant to those involved (i.e., will it be coher-
ent)? Cognitive participation is likely to be enhanced if
staff involved can see both immediate and longer-term
benefits to patients and practice [10,27]. High levels of
cognitive participation will help engage staff in collective
action, but minimising the amount of work required by
participants is also vital. Recruitment and data collection
should be minimally disruptive of existing practices or
workflows: for example, using a researcher to recruit
patients may be more cost-effective than asking GPs to
recruit, as GPs may struggle to remember the study
amongst all the competing demands on their attention
[28]. It is worth noting that trials that offer additional
services are more likely to encourage clinical participa-
tion than those which ask clinicians to abstain from
offering existing services or treatments which have
already become normalised [29]. Reflexive monitoring
can be enhanced by regular feedback, and this can be
personalised (e.g., individual recruitment rates). Newslet-
ters, too, can help foster the sense that the trial is
important, reinforcing cognitive participation and
strengthening collective action.
This is a second opportunity for the NPT to act as a
‘trial killer’. Consideration of the impact of the trial on
the work of the professionals affected may show that the
proposed recruitment or follow-up rates are unfeasible.
Implementation
Once an intervention has been proven effective, the next
step is to ensure wide scale implementation, a task that
often falls to people other than those who did the origi-
nal development and evaluation.
Consider the context
People responsible for implementing a complex inter-
vention need to know the context in which the interven-
tion was developed and evaluated and consider what
differences there are between those and the context for
the planned implementation. For example, a Computer
Decision Support System (CDSS) designed to help call
Table 2 Use of NPT in optimising trial parameters (Continued)
(i.e., participants reflect on
or appraise the
intervention)
Will it be clear what effects the study has had?
Can users/staff contribute feedback about study
procedures?
Quick action in obtaining substantial amendments from ethics
to improve trial procedures (e.g., informed consent procedure;
incentives for patients; information about accessing resources
for clinicians and patients) helped to ensure progress of the
trial.
Can the study procedures be adapted/improved on
the basis of experience?
The WISE trial (ISRCTN90940049 - Evaluation of the WISE (Whole System Informing Self-management Engagement) approach in primary care: improving
outcomes in chronic conditions through effective self-management) [25]. The intervention involves training a whole practice team to provide self-care support to
patients. An exploratory study undertaken prior to the full trial drew on NPT to help optimize the training content and sensitise research to the reaction,
incorporation or rejection of the WISE approach from a service user, professional and organisational perspective.
The context for this trial was UK primary care. Contextual issues that needed consideration in planning the trial included a policy framework which supported
self-management; a performance management system which incentivises GPs to achieve specific clinical targets (the Quality and Outcomes Framework) which
may conflict with self-management and places a requirement on GPs to collate and submit data on a range of performance issues with subsequent implications
for practice income. These data are submitted annually, making the year end an exceptionally busy time for practices so trial-related work is likely to receive
lower priority at this time.
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centre workers triage emergency calls to the Ambulance
Service is likely to require reconfiguration for use in a
nonemergency context, where the epidemiology of
health problems leading to calls will be quite different.
Define the intervention to be implemented
One of the problems with implementing complex inter-
ventions is defining the intervention. In the example
given above of a Computer Decision Support System, is
the intervention the software or the combination of the
software and the staff working in the call centre?
Undertake an NPT analysis of the implementation
Having considered the context, defined the intervention
and thought about all the different groups of staff likely
to be affected by the implementation, the implementer
is ready to undertake an NPT analysis. We present in
Table 3 a worked example of an NPT analysis underta-
ken prior to implementation of robotic urological sur-
gery in Italy. In this example, the intervention was easy
to describe and distinguish from current practice as it
required new technology, equipment and skills. It was
likely to benefit patients and professionals at centres
offering the new surgical technique, while professionals
working at centres not offering it might feel disadvan-
taged by the potential loss of patients. The NPT analysis
allowed the Health Board responsible for introducing
robotic surgery to identify this as a potential problem
before starting the implementation programme and to
consider strategies for addressing this. Similarly, the
NPT analysis identified the need for extensive training
of staff in selected units, consideration of the impact of
the new technology on patient referral patterns (and
how this could destabilise some provider units), and the
need for ongoing monitoring and feedback to units to
allow them to reflect on the service offered.
Summary
The goal of research into complex interventions is to
improve health. This requires first that researchers
ensure that interventions they develop and evaluate can
be widely implemented and second that their evalua-
tions provide definitive assessments of efficacy and
effectiveness. NPT provides a framework that can help
with both tasks. The explicit consideration of the imple-
mentation potential of an intervention is, we believe,
rarely done by trialists before a trial commences. This
may partially explain the ‘know-do’ gap between evi-
dence about effective interventions and routine clinical
practice. Moreover, NPT acknowledges that healthcare
is a collective activity requiring a multitude of interac-
tions between professionals, patients, managers and
others. An intervention that appears to affect only one
individual or group may, on closer inspection, require a
successful chain of interactions. NPT will not solve
these problems, but it can help to identify how links
between participants may be affected by the intervention
and how the intervention might be modified to support
these interactions. This is, we believe, a clear strength of
NPT compared to other approaches to implementation,
which tend to focus principally on the needs of one pro-
fessional group or level at a time, with less consideration
given to the wider system issues. For example, theories
of individual preferences (in economics) [30], intentions
(in psychology) [31] and interests (in sociology) [32]
support understanding of how participants in these col-
lective activities frame behaviour. However, because
such theories focus on individual and not group pro-
cesses, they are inevitably much less successful in
accounting for organisational processes characterised by
complexity and emergence, where multiple confounders
act upon behaviour. Alternatively, approaches such as
Rogers’ Diffusion of Innovations focus on whole sys-
tems, with little consideration of component parts [33].
Nor do other approaches to implementation consider
the ‘work’ that needs to be done to maintain the inter-
vention in routine practice, either by professionals or by
patients [24,34]. A recent Cochrane review on the devel-
opment of tailored interventions to overcome barriers to
change found that such interventions were more likely
to improve professional practice, but that the methods
used to identify barriers and develop tailored interven-
tions needed further development [35]. We suggest that
the clear theoretical framework offered by NPT, addres-
sing both individual and organisational level factors, can
help with both these tasks.
NPT is a new theory, and we believe that it offers tri-
alists something that has to date been lacking: a consis-
tent framework that can be used to describe and judge
implementation potential but also, importantly, to
design and improve complex interventions. For this rea-
son, it is worth building up an empirical body of work
to test NPT in practice. Too many trials fail to have an
impact on practice [11], a situation no trialist wants and
which will not change unless interventions are devel-
oped with an explicit theoretical framework. We con-
sider that NPT is a strong candidate framework and
encourage trialists, both those designing trials of com-
plex interventions and those designing clinical trials, to
consider using it in their next trial.
Acknowledgements
We are grateful to the NIHR School of Primary Care Research for funding a
Peer Learning Group which allowed the development of the ideas in this
paper. We thank Jan Legge and Orla O’Donnell for organising the annual
meetings of the Peer Learning Group.
Author details
1Research Department of Primary Care and Population Health, University
College London, Upper Floor 3, Royal Free Hospital, Rowland Hill Street,
London NW3 2PF, UK. 2Division of Clinical & Population Science and
Education, Mackenzie Building, University of Dundee, Kirsty Semple Way,
Murray et al. BMC Medicine 2010, 8:63
http://www.biomedcentral.com/1741-7015/8/63
Page 8 of 11
Table 3 Use of NPT in implementing complex interventions
NPT Components Questions to consider within the NPT framework Example: an NPT evaluation of robotic urological surgery
Coherence Is the intervention easy to describe? The intervention is easily distinguishable from current surgical
techniques by the technology involved, new skills required, new
operating theatre equipment needed and higher costs of the
service.
Is it clearly distinct from other interventions?
(i.e., meaning and sense
making by participants)
Does it have a clear purpose for all relevant
participants?
Do participants have a shared sense of its purpose?
What benefits will the intervention bring and to
whom?
It is expected to improve the performance and the clinical
outcomes of minimally invasive techniques.
Are these benefits likely to be valued by potential
participants?
Will it fit with the overall goals and activity of the
organisation?
Cognitive participation Are target user groups likely to think the intervention
is a good idea?
Professionals offered the technology are likely to be enthusiastic
and prepared to invest their time and training in it.
(i.e., commitment and
engagement by
participants)
Will they see the point easily?
Surgeons not offered the technology might not see it as
advantageous and might discourage their patients from accessing
the technology, particularly as this would mean the patient
transferring to another centre.
Will they be prepared to invest time, energy and work
in it?
Collective action How will the intervention affect the work of user
groups?
Surgeons working in centres not offering robotic surgery may
hesitate to offer this treatment option which requires onward
referral of the patient and may adversely affect the surgeon-
patient relationship.
Will it promote or impede their work?
(i.e., the work
participants do to make
the trial function)
What effect will it have on consultations?
Will staff require extensive training before they can
use it?
Most surgeons do not have the necessary skills and knowledge
to use the new technology. New training programmes with
defined content and assessment procedures will be needed to
ensure accountability and confidence.
How compatible is it with existing work practices? Establishing a highly specialized surgical network, where patients
are referred from ‘nondoers’ to ‘doers’ and where surgical teams
move between hospitals, will contribute to the development of a
surgical elite, which will attract patients, resources, research
resources and prestige. The impact of this will need to be
monitored.
What impact will it have on division of labour,
resources, power, and responsibility between different
professional groups?
Will it fit with the overall goals and activity of the
organisation?
Centres which are offered and choose to adopt the new service
are likely to view it as having a positive impact on their goals, as
it is likely to increase patient numbers. However, they will have to
invest resources to achieve the structural and organizational
changes required and take responsibility for accommodating the
expected increased flow of patients, for training programmes and
for specific risk management programmes.
Reflexive Monitoring How are users likely to perceive the intervention once
it has been in use for a while?
Systematic review evidence details the expected clinical impact
of the new technology. Clinical audit will be undertaken to
determine whether the expected benefits are being achieved in
routine clinical practice.
(i.e., participants reflect
on or appraise the trial)
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